HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405
医学
西妥昔单抗
贝伐单抗
肿瘤科
危险系数
结直肠癌
内科学
无进展生存期
癌症
化疗
置信区间
作者
Francesca Battaglin,Fang‐Shu Ou,Xueping Qu,Howard S. Höchster,Donna Niedzwiecki,Richard M. Goldberg,Robert J. Mayer,Karam Ashouri,Tyler Zemla,Charles D. Blanke,Alan P. Venook,Omar Kabbarah,Heinz‐Josef Lenz,Federico Innocenti
出处
期刊：Journal of Clinical Oncology [American Society of Clinical Oncology] 日期：2024-03-08卷期号：42 (16): 1890-1902被引量：7
The phase III Cancer and Leukemia Group B (CALGB)/SWOG 80405 trial found no difference in overall survival (OS) in patients with metastatic colorectal cancer receiving first-line chemotherapy in combination with either bevacizumab or cetuximab. We investigated the potential prognostic and predictive value of
科研小民工
kingwill
苏卿
劲秉
SYLH
请叫我风吹麦浪
迟大猫
36456657
缓慢如南
VDC
龙玄泽
一一
pluto
怕黑荠
坚强的广山
cdercder
爱静静
大脑袋
sutharsons
Zn
皖公网安备34019202002308
